US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.910
  • +0.360+3.12%
Close Nov 22 16:00 ET
  • 11.910
  • 0.0000.00%
Post 20:01 ET
502.60MMarket Cap-3943P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
Operating revenue
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
Cost of revenue
3.63%2.45M
-8.76%2.23M
-23.71%1.73M
22.30%9.36M
1.02%2.29M
17.18%2.37M
32.34%2.44M
48.52%2.27M
48.42%7.65M
42.42%2.26M
Gross profit
23.08%22.75M
4.94%19.62M
14.24%17.05M
29.36%73.35M
34.21%21.24M
31.31%18.49M
26.68%18.7M
23.99%14.93M
32.22%56.7M
8.53%15.83M
Operating expense
25.98%40.3M
33.39%45.46M
15.74%42.79M
2.32%138.89M
-0.71%35.85M
-0.56%31.99M
1.81%34.08M
8.75%36.97M
0.42%135.74M
4.67%36.11M
Selling and administrative expenses
33.03%28.94M
33.62%30.06M
11.54%27.3M
12.60%93.27M
13.48%24.55M
14.07%21.76M
7.97%22.49M
14.90%24.47M
-5.37%82.84M
1.01%21.63M
Research and development costs
11.00%11.36M
32.96%15.4M
23.97%15.49M
-13.78%45.61M
-21.93%11.3M
-21.87%10.23M
-8.35%11.58M
-1.56%12.5M
11.05%52.91M
10.66%14.48M
Operating profit
-29.96%-17.55M
-67.98%-25.84M
-16.76%-25.74M
17.09%-65.54M
27.97%-14.61M
25.36%-13.5M
17.81%-15.38M
-0.40%-22.05M
14.36%-79.04M
-1.84%-20.28M
Net non-operating interest income expense
101.21%36K
47.71%-1.74M
77.68%-649K
-60.99%-12.07M
-3.85%-2.86M
-32.27%-2.98M
-57.56%-3.33M
-938.57%-2.91M
-3,637.74%-7.5M
-1,970.68%-2.75M
Non-operating interest income
230.18%2.76M
295.86%1.72M
178.76%1.8M
181.56%2.64M
54.80%726K
89.34%835K
239.84%435K
32,150.00%645K
156.99%938K
2,245.00%469K
Non-operating interest expense
-28.68%2.72M
-7.98%3.46M
-31.13%2.45M
74.39%14.72M
11.26%3.59M
41.61%3.82M
67.98%3.76M
1,159.93%3.55M
--8.44M
--3.22M
Other net income (expense)
-12.30%-6.07M
-7.69%-5.79M
-11.53%-5.84M
3.60%-20.71M
8.77%-4.69M
-13.09%-5.41M
7.87%-5.37M
10.14%-5.24M
-24.27%-21.49M
29.21%-5.14M
Gain on sale of security
-7.96%-5.92M
-8.03%-5.77M
-8.35%-5.66M
0.03%-21.55M
-8.34%-5.51M
-13.70%-5.48M
8.38%-5.34M
10.33%-5.22M
-24.68%-21.56M
30.80%-5.08M
Other non- operating income (expenses)
-322.54%-158K
53.33%-14K
-1,120.00%-183K
1,063.89%838K
1,388.89%812K
91.89%71K
---30K
-275.00%-15K
--72K
---63K
Income before tax
-7.74%-23.58M
-38.55%-33.37M
-6.76%-32.23M
8.98%-98.32M
21.36%-22.16M
12.87%-21.89M
9.67%-24.08M
-7.57%-30.19M
1.23%-108.03M
-3.17%-28.18M
Income tax
1,111.11%91K
-29.63%38K
157.14%54K
123.36%3.92M
459.36%3.85M
-101.27%-9K
68.75%54K
-93.54%21K
21.12%1.76M
-39.40%689K
Net income
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Net income continuous Operations
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Minority interest income
Net income attributable to the parent company
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Basic earnings per share
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
Diluted earnings per share
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 20.87%25.2M3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M33.96%64.36M11.86%18.09M
Operating revenue 20.87%25.2M3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M33.96%64.36M11.86%18.09M
Cost of revenue 3.63%2.45M-8.76%2.23M-23.71%1.73M22.30%9.36M1.02%2.29M17.18%2.37M32.34%2.44M48.52%2.27M48.42%7.65M42.42%2.26M
Gross profit 23.08%22.75M4.94%19.62M14.24%17.05M29.36%73.35M34.21%21.24M31.31%18.49M26.68%18.7M23.99%14.93M32.22%56.7M8.53%15.83M
Operating expense 25.98%40.3M33.39%45.46M15.74%42.79M2.32%138.89M-0.71%35.85M-0.56%31.99M1.81%34.08M8.75%36.97M0.42%135.74M4.67%36.11M
Selling and administrative expenses 33.03%28.94M33.62%30.06M11.54%27.3M12.60%93.27M13.48%24.55M14.07%21.76M7.97%22.49M14.90%24.47M-5.37%82.84M1.01%21.63M
Research and development costs 11.00%11.36M32.96%15.4M23.97%15.49M-13.78%45.61M-21.93%11.3M-21.87%10.23M-8.35%11.58M-1.56%12.5M11.05%52.91M10.66%14.48M
Operating profit -29.96%-17.55M-67.98%-25.84M-16.76%-25.74M17.09%-65.54M27.97%-14.61M25.36%-13.5M17.81%-15.38M-0.40%-22.05M14.36%-79.04M-1.84%-20.28M
Net non-operating interest income expense 101.21%36K47.71%-1.74M77.68%-649K-60.99%-12.07M-3.85%-2.86M-32.27%-2.98M-57.56%-3.33M-938.57%-2.91M-3,637.74%-7.5M-1,970.68%-2.75M
Non-operating interest income 230.18%2.76M295.86%1.72M178.76%1.8M181.56%2.64M54.80%726K89.34%835K239.84%435K32,150.00%645K156.99%938K2,245.00%469K
Non-operating interest expense -28.68%2.72M-7.98%3.46M-31.13%2.45M74.39%14.72M11.26%3.59M41.61%3.82M67.98%3.76M1,159.93%3.55M--8.44M--3.22M
Other net income (expense) -12.30%-6.07M-7.69%-5.79M-11.53%-5.84M3.60%-20.71M8.77%-4.69M-13.09%-5.41M7.87%-5.37M10.14%-5.24M-24.27%-21.49M29.21%-5.14M
Gain on sale of security -7.96%-5.92M-8.03%-5.77M-8.35%-5.66M0.03%-21.55M-8.34%-5.51M-13.70%-5.48M8.38%-5.34M10.33%-5.22M-24.68%-21.56M30.80%-5.08M
Other non- operating income (expenses) -322.54%-158K53.33%-14K-1,120.00%-183K1,063.89%838K1,388.89%812K91.89%71K---30K-275.00%-15K--72K---63K
Income before tax -7.74%-23.58M-38.55%-33.37M-6.76%-32.23M8.98%-98.32M21.36%-22.16M12.87%-21.89M9.67%-24.08M-7.57%-30.19M1.23%-108.03M-3.17%-28.18M
Income tax 1,111.11%91K-29.63%38K157.14%54K123.36%3.92M459.36%3.85M-101.27%-9K68.75%54K-93.54%21K21.12%1.76M-39.40%689K
Net income -8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M
Net income continuous Operations -8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M
Minority interest income
Net income attributable to the parent company -8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M
Basic earnings per share 19.12%-0.5511.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.33.02%-4.813.94%-1.22
Diluted earnings per share 19.12%-0.5511.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.33.02%-4.813.94%-1.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data